{
    "id": 32166,
    "fullName": "PALB2 L1119P",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PALB2 L1119P lies within WD repeat 6 of the Palb2 protein (UniProt.org). L1119P results in decreased nuclear localization, Brca2 binding, and recruitment to DNA damage sites and impaired homology-directed DNA repair activity compared to wild-type Palb2 in cultured cells (PMID: 31586400), however, demonstrates similar Rad51 foci formation and increased Rad51 foci intensity to wild-type (PMID: 31586400), and does not demonstrate reduced homology-directed DNA repair activity compared to wild-type Palb2 in cultured cells lacking Tp53 (PMID: 31636395,\u00a0PMID: 31757951), and therefore, its effect on Palb2 protein function is unknown.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17535,
                    "pubMedId": 31757951,
                    "title": "Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31757951"
                },
                {
                    "id": 17558,
                    "pubMedId": 31586400,
                    "title": "A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31586400"
                },
                {
                    "id": 17540,
                    "pubMedId": 31636395,
                    "title": "Functional characterization of 84 PALB2 variants of uncertain significance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31636395"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 79728,
        "geneSymbol": "PALB2",
        "terms": [
            "PALB2",
            "FANCN",
            "PNCA3"
        ]
    },
    "variant": "L1119P",
    "createDate": "01/21/2020",
    "updateDate": "03/26/2020",
    "referenceTranscriptCoordinates": {
        "id": 186796,
        "transcript": "NM_024675",
        "gDna": "chr16:g.23603664A>G",
        "cDna": "c.3356T>C",
        "protein": "p.L1119P",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20285,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing PALB2 L1119P were sensitive to treatment with Lynparza (olaparib), demonstrating decreased cell growth in culture (PMID: 31586400).",
            "molecularProfile": {
                "id": 34673,
                "profileName": "PALB2 L1119P"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17558,
                    "pubMedId": 31586400,
                    "title": "A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31586400"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20284,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, osteosarcoma cells expressing PALB2 L1119P were sensitive to treatment with Lynparza (olaparib), demonstrating decreased cell growth in culture (PMID: 31586400).",
            "molecularProfile": {
                "id": 34673,
                "profileName": "PALB2 L1119P"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 3347,
                "name": "osteosarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17558,
                    "pubMedId": 31586400,
                    "title": "A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31586400"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34673,
            "profileName": "PALB2 L1119P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186796,
            "transcript": "NM_024675",
            "gDna": "chr16:g.23603664A>G",
            "cDna": "c.3356T>C",
            "protein": "p.L1119P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}